AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

DGX · NYSE · Medical - Diagnostics & Research

Quest Diagnostics (DGX)

Provides clinical testing, pathology, and laboratory services through a North American network.

$232.58

vs last close−2.18 (−0.93%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	2,295	2,288	2,366	2,397	2,488	2,621	2,652	2,761	2,816	2,806	2,895	3,043
Cost of revenue	1,541	1,548	1,595	1,593	1,677	1,763	1,789	1,818	1,867	1,892	1,953	2,016
Gross profit	754	740	771	804	811	858	863	943	949	914	942	1,027
	412	473	471	449	481	497	517	505	563	523	543	568
	380	402	436	406	448	466	476	486	501	486	504	529
General & administrative	0	0	0	0	0	0	0	0	0	0	504	0
Other expenses	32	71	35	43	33	31	41	19	62	37	39	39
Operating income	342	267	300	355	330	361	346	438	386	391	399	459
	−37	−22	−26	−41	−28	−57	−52	−45	−50	−54	−65	−47
Interest income	1	6	6	3	9	7	5	2	3	3	0	0
Interest expense	41	46	49	47	58	72	72	69	69	67	63	63
Other non-operating income	2	−16	−15	−6	−24	−10	−2	−15	−19	−10	2	16
Income before tax	305	245	274	314	302	304	294	393	336	337	334	412
Income tax expense	68	40	66	74	65	68	59	97	77	81	74	88
Net income from continuing operations	237	205	208	240	237	236	235	296	259	256	260	324
Other adjustments	0	0	0	0	0	0	0	0	0	0	4	10
Net income	225	192	194	229	226	222	220	282	245	245	252	320
EPS, basic	$1.99	$1.72	$1.74	$2.05	$2.01	$1.98	$1.97	$2.51	$2.18	$2.21	$2.27	$2.88
EPS, diluted	$1.96	$1.70	$1.72	$2.04	$1.99	$1.95	$1.94	$2.47	$2.16	$2.18	$2.24	$2.84
Weighted average shares, basic	112	112	111	111	112	111	111	112	112	111	110	110
Weighted average shares, diluted	114	113	112	112	113	113	113	113	113	112	112	112
EBITDA	451	392	431	478	479	507	488	596	547	546	434	481
Depreciation & amortization	111	109	116	117	125	135	140	143	142	145	37	38
EBIT	340	283	315	361	354	371	348	453	405	401	397	443